Primary Brain Tumor Patient and Caregiver Congruence in Symptom Report Using the M.D. Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT)
If you and your caregiver agree to take part in this study, you will both complete 2
questionnaires. You will be in separate rooms when you complete the questionnaires.
The first questionnaire is a demographic questionnaire that asks basic questions such as
your age and employment status.
Your second questionnaire asks about any brain cancer symptoms that you may be experiencing,
and asks you to rate how severe they may be.
Your caregiver's second questionnaire asks the same questions as yours. It asks the
caregiver to rate how severe he or she believes your symptoms may be.
In total, the questionnaires should take about 10 minutes to complete.
The study staff will review the questionnaire responses right away. If you rate any symptom
as severe as 7 or higher, the study staff will tell you to contact your doctor who is
treating the cancer. The study staff will also contact your doctor who is treating the
cancer. Otherwise, your questionnaire responses will only be used for research and there
are no plans to contact your doctor.
Length of Study Participation:
After you and your caregiver complete the questionnaires this one time, your and your
caregivers' active participation in this study will be over.
The study chair will also collect information from your medical record. This information
will include your medical history and the results of the neurocognitive testing (routine
tests of "thinking" skills such as your memory and concentration).
This is an investigational study. Up to 120 patients and 120 caregivers will take part in
this study. All will be enrolled at M. D. Anderson.
Observational Model: Case Control, Time Perspective: Prospective
Mean Caregiver Ratings of Symptom Severity (using the mean of all the items from the MDASI-BT) in Patient-Caregiver Dyads
Participant involvment is 10 minutes to complete MDASI-BT questionnaire
Mark R. Gilbert, MD
M.D. Anderson Cancer Center
United States: Institutional Review Board
|UT MD Anderson Cancer Center||Houston, Texas 77030|